Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2023

Open Access 01-12-2023 | Research

Association between life’s essential 8 and biological ageing among US adults

Authors: Ronghuai Zhang, Min Wu, Wei Zhang, Xuna Liu, Jie Pu, Tao Wei, Zhanfang Zhu, Zhiguo Tang, Na Wei, Bo Liu, Qianwei Cui, Junkui Wang, Fuqiang Liu, Ying Lv

Published in: Journal of Translational Medicine | Issue 1/2023

Login to get access

Abstract

Background

Biological ageing is tightly linked to cardiovascular disease (CVD). We aimed to investigate the relationship between Life’s Essential 8 (LE8), a currently updated measure of cardiovascular health (CVH), and biological ageing.

Methods

This cross-sectional study selected adults ≥ 20 years of age from the 2005–2010 National Health and Nutrition Examination Survey. LE8 scores (range 0–100) were obtained from measurements based on American Heart Association definitions, divided into health behavior and health factor scores. Biological ageing was assessed by different methods including phenotypic age, phenotypic age acceleration (PhenoAgeAccel), biological age and biological age acceleration (BioAgeAccel). Correlations were analyzed by weighted linear regression and restricted cubic spline models.

Results

Of the 11,729 participants included, the mean age was 47.41 ± 0.36 years and 5983 (51.01%) were female. The mean phenotypic and biological ages were 42.96 ± 0.41 and 46.75 ± 0.39 years, respectively, and the mean LE8 score was 67.71 ± 0.35. After adjusting for potential confounders, higher LE8 scores were associated with lower phenotypic age, biological age, PhenoAgeAccel, and BioAgeAccel, with nonlinear dose–response relationships. Negative associations were also found between health behavior and health factor scores and biological ageing, and were stronger for health factors. In health factor-specific analyses, the β negativity was greater for blood glucose and blood pressure. The inverse correlations of LE8 scores with phenotypic age and biological age in the stratified analyses remained solid across strata.

Conclusions

LE8 and its subscale scores were strongly negatively related to biological ageing. Encouraging optimal CVH levels may be advantageous in preventing and slowing down ageing.
Appendix
Available only for authorised users
Literature
1.
Zhang W, Peng S-F, Chen L, Chen H-M, Cheng X-E, Tang Y-H. Association between the oxidative balance score and telomere length from the National Health and Nutrition Examination Survey 1999–2002. Oxid Med Cell Longev. 2022;2022:1345071.PubMedPubMedCentral
2.
3.
Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159:709–13.PubMedPubMedCentral
4.
Hahad O, Frenis K, Kuntic M, Daiber A, Münzel T. Accelerated aging and age-related diseases (CVD and Neurological) due to air pollution and traffic noise exposure. Int J Mol Sci. 2021;22:2419.PubMedPubMedCentral
5.
Roetker NS, Pankow JS, Bressler J, Morrison AC, Boerwinkle E. Prospective study of epigenetic age acceleration and incidence of cardiovascular disease outcomes in the ARIC Study (Atherosclerosis Risk in Communities). Circ Genom Precis Med. 2018;11: e001937.PubMedPubMedCentral
6.
Mwasongwe S, Gao Y, Griswold M, Wilson JG, Aviv A, Reiner AP, et al. Leukocyte telomere length and cardiovascular disease in African Americans: The Jackson Heart Study. Atherosclerosis. 2017;266:41–7.PubMedPubMedCentral
7.
Huang R-C, Lillycrop KA, Beilin LJ, Godfrey KM, Anderson D, Mori TA, et al. Epigenetic Age Acceleration in Adolescence Associates With BMI, Inflammation, and Risk Score for Middle Age Cardiovascular Disease. J Clin Endocrinol Metab. 2019;104:3012–24.PubMedPubMedCentral
8.
Ammous F, Zhao W, Ratliff SM, Mosley TH, Bielak LF, Zhou X, et al. Epigenetic age acceleration is associated with cardiometabolic risk factors and clinical cardiovascular disease risk scores in African Americans. Clin Epigenetics. 2021;13:55.PubMedPubMedCentral
9.
Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613.PubMed
10.
Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, et al. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146:e18-43.PubMedPubMedCentral
11.
Lloyd-Jones DM, Ning H, Labarthe D, Brewer L, Sharma G, Rosamond W, et al. Status of cardiovascular health in US Adults and children using the american heart association’s new “Life’s Essential 8” metrics: prevalence estimates from the national health and nutrition examination survey (NHANES), 2013 through 2018. Circulation. 2022;146:822–35.PubMed
12.
Klemera P, Doubal S. A new approach to the concept and computation of biological age. Mech Ageing Dev. 2006;127:240–8.PubMed
13.
Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10:573–91.PubMed
14.
Hertel J, Friedrich N, Wittfeld K, Pietzner M, Budde K, Van der Auwera S, et al. Measuring biological age via metabonomics: the metabolic age score. J Proteome Res. 2016;15:400–10.PubMed
15.
Krebs-Smith SM, Pannucci TE, Subar AF, Kirkpatrick SI, Lerman JL, Tooze JA, et al. Update of the healthy eating index: HEI-2015. J Acad Nutr Diet. 2018;118:1591–602.PubMedPubMedCentral
16.
Levine ME. Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age? J Gerontol A Biol Sci Med Sci. 2013;68:667–74.PubMed
17.
Hu Y, Wang X, Huan J, Zhang L, Lin L, Li Y, et al. Effect of dietary inflammatory potential on the aging acceleration for cardiometabolic disease: a population-based study. Front Nutr. 2022;9:1048448.PubMedPubMedCentral
18.
Gebreab SY, Manna ZG, Khan RJ, Riestra P, Xu R, Davis SK. Less than ideal cardiovascular health is associated with shorter leukocyte telomere length: The National Health and Nutrition Examination Surveys, 1999–2002. J Am Heart Assoc. 2017;6: e004105.PubMedPubMedCentral
19.
Pottinger TD, Khan SS, Zheng Y, Zhang W, Tindle HA, Allison M, et al. Association of cardiovascular health and epigenetic age acceleration. Clin Epigenetics. 2021;13:42.PubMedPubMedCentral
20.
21.
Aunan JR, Watson MM, Hagland HR, Søreide K. Molecular and biological hallmarks of ageing. Br J Surg. 2016;103:e29-46.PubMed
22.
J G, E W, J S, Ab M, Bk K. Targeting the molecular & cellular pillars of human aging with exercise. The FEBS journal. 2023;290 (Acesed1 Aug 2023).
23.
Klaips CL, Jayaraj GG, Hartl FU. Pathways of cellular proteostasis in aging and disease. J Cell Biol. 2018;217:51–63.PubMedPubMedCentral
24.
Man AWC, Li H, Xia N. Impact of lifestyles (diet and exercise) on vascular health: oxidative stress and endothelial function. Oxid Med Cell Longev. 2020;2020:1496462.PubMedPubMedCentral
25.
Shih C-C, Shih Y-L, Chen J-Y. The association between homocysteine levels and cardiovascular disease risk among middle-aged and elderly adults in Taiwan. BMC Cardiovasc Disord. 2021;21:191.PubMedPubMedCentral
26.
Stakos DA, Stamatelopoulos K, Bampatsias D, Sachse M, Zormpas E, Vlachogiannis NI, et al. The alzheimer’s disease amyloid-beta hypothesis in cardiovascular aging and disease: JACC focus seminar. J Am Coll Cardiol. 2020;75:952–67.PubMedPubMedCentral
27.
Zheng J, Zhou R, Li F, Chen L, Wu K, Huang J, et al. Association between dietary diversity and cognitive impairment among the oldest-old: findings from a nationwide cohort study. Clin Nutr. 2021;40:1452–62.PubMed
28.
29.
Zhou Y-F, Song X-Y, Pan A, Koh W-P. Nutrition and healthy ageing in Asia: a systematic review. Nutrients. 2023;15:3153.PubMedPubMedCentral
30.
31.
Khalafi M, Akbari A, Symonds ME, Pourvaghar MJ, Rosenkranz SK, Tabari E. Influence of different modes of exercise training on inflammatory markers in older adults with and without chronic diseases: a systematic review and meta-analysis. Cytokine. 2023;169: 156303.PubMed
32.
Majdi A, Kamari F, Vafaee MS, Sadigh-Eteghad S. Revisiting nicotine’s role in the ageing brain and cognitive impairment. Rev Neurosci. 2017;28:767–81.PubMed
33.
Zhang Y, Xia X, Zhang T, Zhang C, Liu R, Yang Y, et al. Relation between sleep disorders and post-stroke cognitive impairment. Front Aging Neurosci. 2023;15:1036994.PubMedPubMedCentral
34.
Kusters CDJ, Klopack ET, Crimmins EM, Seeman TE, Cole S, Carroll JE. Short sleep and insomnia are associated with accelerated epigenetic age. Psychosom Med. 2023;3:363.
35.
36.
Hablitz LM, Nedergaard M. The glymphatic system: a novel component of fundamental neurobiology. J Neurosci. 2021;41:7698–711.PubMedPubMedCentral
37.
Am M, B R, S T, A B, M B, Sr B, et al. Sleep, brain vascular health and ageing. GeroScience. 2020;42. (Accessed 1 Aug 2023)
38.
Holme I, Tonstad S. Survival in elderly men in relation to midlife and current BMI. Age Ageing. 2015;44:434–9.PubMed
39.
Leigh L, Byles JE, Jagger C. BMI and healthy life expectancy in old and very old women. Br J Nutr. 2016;116:692–9.PubMed
40.
Hajek A, König H-H. The curvilinear effect of BMI on functional health-evidence of the long-running german ageing survey. Obes Facts. 2017;10:252–60.PubMedPubMedCentral
41.
Johnson LC, Martens CR, Santos-Parker JR, Bassett CJ, Strahler TR, Cruickshank-Quinn C, et al. Amino acid and lipid associated plasma metabolomic patterns are related to healthspan indicators with ageing. Clin Sci (Lond). 2018;132:1765–77.PubMed
42.
Johnson LC, Parker K, Aguirre BF, Nemkov TG, D’Alessandro A, Johnson SA, et al. The plasma metabolome as a predictor of biological aging in humans. Geroscience. 2019;41:895–906.PubMedPubMedCentral
43.
Rubio-Tomás T, Tavernarakis N. Lipid metabolism and ageing in Caenorhabditis elegans: a complex interplay. Biogerontology. 2022;23:541–57.PubMed
44.
Liu H-J, Miao H, Yang J-Z, Liu F, Cao G, Zhao Y-Y. Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis. Ageing Res Rev. 2023;85: 101861.PubMed
45.
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396:413–46.
46.
Bencivenga L, De Souto BP, Rolland Y, Hanon O, Vidal J-S, Cestac P, et al. Blood pressure variability: a potential marker of aging. Ageing Res Rev. 2022;80: 101677.PubMed
47.
Donato AJ, Machin DR, Lesniewski LA. Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ Res. 2018;123:825–48.PubMedPubMedCentral
48.
Gutteridge DS, Segal A, McNeil JJ, Beilin L, Brodtmann A, Chowdhury EK, et al. The relationship between long-term blood pressure variability and cortical thickness in older adults. Neurobiol Aging. 2023;129:157–67.PubMed
49.
Walsh EI, Shaw M, Sachdev P, Anstey KJ, Cherbuin N. Brain atrophy in ageing: ESTIMATING effects of blood glucose levels vs. other type 2 diabetes effects. Diabet Metabol. 2018;44:80–3.
50.
Brundel M, Kappelle LJ, Biessels GJ. Brain imaging in type 2 diabetes. Eur Neuropsychopharmacol. 2014;24:1967–81.PubMed
51.
Shaw ME, Nettersheim J, Sachdev PS, Anstey KJ, Cherbuin N. Higher fasting plasma glucose is associated with increased cortical thinning over 12 years: the PATH through life study. Brain Topogr. 2017;30:408–16.PubMed
52.
Artola A. Diabetes mellitus- and ageing-induced changes in the capacity for long-term depression and long-term potentiation inductions: toward a unified mechanism. Eur J Pharmacol. 2013;719:161–9.PubMed
Metadata
Title
Association between life’s essential 8 and biological ageing among US adults
Authors
Ronghuai Zhang
Min Wu
Wei Zhang
Xuna Liu
Jie Pu
Tao Wei
Zhanfang Zhu
Zhiguo Tang
Na Wei
Bo Liu
Qianwei Cui
Junkui Wang
Fuqiang Liu
Ying Lv
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2023
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-023-04495-8

Other articles of this Issue 1/2023

Journal of Translational Medicine 1/2023 Go to the issue

Research

Investigations of brain-wide functional and structural networks of dopaminergic and CamKIIα-positive neurons in VTA with DREADD-fMRI and neurotropic virus tracing technologies

Research

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

Research

The comprehensive study on the role of POSTN in fetal congenital heart disease and clinical applications

Research

Single-cell analysis of white adipose tissue reveals the tumor-promoting adipocyte subtypes

Correction

Correction: Mitochondria-derived vesicles and their potential roles in kidney stone disease

Research

ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits